^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MFN1 (Mitofusin 1)

i
Other names: MFN1, Mitofusin 1, Transmembrane GTPase MFN1, Mitofusin-1, Fzo Homolog, FLJ20693, Mitochondrial Transmembrane GTPase FZO-2, Mitochondrial Transmembrane GTPase Fzo-1, Putative Transmembrane GTPase, Hfzo1, Hfzo2
Associations
Trials
1m
Paclitaxel impairs mitochondrial dynamics in human sensory-like neuron cells. (PubMed, Toxicol Appl Pharmacol)
Together, our data suggest that impairment in mitochondrial dynamics of sensory neurons contributes to paclitaxel neurotoxicity and, consequently, to nociception. Therefore, preventing mitochondrial fission may be a strategy to prevent PTX-induced neurotoxicity, opening a new perspective to understanding the mechanisms involved in the development of PTX-induced neuropathy.
Journal
|
ATF3 (Activating Transcription Factor 3) • MFN1 (Mitofusin 1) • MFN2 (Mitofusin 2)
|
paclitaxel
4ms
Mitofusin 1 in mitochondrial quality control and anti-inflammatory responses in nucleus pulposus cells during disc degeneration. (PubMed, Sci Rep)
In vivo, MFN1-knockout NPCs exhibited reduced ECM proteoglycan levels, reinforcing its role in disc homeostasis. These findings suggest that although MFN1 and MFN2 respond to TNF-α, MFN1 reacts more robustly, making it a more promising target under inflammatory stress.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • MFN1 (Mitofusin 1) • MFN2 (Mitofusin 2)
4ms
NDUFAB1 promotes hepatocellular carcinoma progression by disrupting mitochondrial homeostasis and mitophagy pathway. (PubMed, Int Immunopharmacol)
Collectively, NDUFAB1 likely promotes HCC progression by disrupting mitochondrial homeostasis, potentially through activation of the mitophagy pathway. These findings demonstrate that NDUFAB1 may be used as an independent prognostic risk factor in HCC patients.
Journal
|
MFN1 (Mitofusin 1) • MFN2 (Mitofusin 2)
5ms
Dihuang Yinzi Regulates cAMP/PKA/CREB-BDNF to Improve Synaptic Plasticity in APP/PS1 Mice: A Study Based on Brain Metabolomics. (PubMed, Chin J Integr Med)
DHYZ could improve mitochondrial dynamics and synaptic plasticity in APP/PS1 mice, inhibit oxidative stress, and thereby enhancing learning and memory abilities in APP/PS1 mice. Its mechanism might be related to activation of the cAMP/PKA/CREB-BDNF signaling pathway.
Preclinical • Journal • Metabolomic study
|
NAPSA (Napsin A Aspartic Peptidase) • SYP (Synaptophysin) • BDNF (Brain Derived Neurotrophic Factor) • DLG4 (Discs Large MAGUK Scaffold Protein 4) • MFN1 (Mitofusin 1)
5ms
Cisplatin transported by COX17 induces cochlear damage by binding Myosin IIA to regulate cell pyroptosis induced by mitochondrial dysfunction. (PubMed, Life Sci)
These findings offer new insights and potential targets for the preventing and treatment of cisplatin-induced ototoxicity.
Journal
|
MFN1 (Mitofusin 1) • MFN2 (Mitofusin 2)
|
cisplatin
6ms
C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia. (PubMed, Sci Rep)
Finally, MFN1 editing correlated with prolonged time to treatment and overall survival in CLL patients. Summarizing, we identified a novel ADARB1 function as C to U editing regulator, which regulates MFN1 splicing and MFN1 S329L recoding with pathogenic relevance in CLL.
Journal
|
ADARB1 (Adenosine Deaminase RNA Specific B1) • MFN1 (Mitofusin 1)
7ms
PA28γ promotes the malignant progression of tumor by elevating mitochondrial function via C1QBP. (PubMed, Elife)
High co-expression predicted poor prognosis in OSCC patients. Thus, PA28γ stabilizes C1QBP via N-terminal interaction to drive mitochondrial OXPHOS and tumor progression, highlighting its potential as a therapeutic target.
Journal
|
MFN1 (Mitofusin 1)
10ms
Lycopene ameliorates D-galactose-induced hepatic senescence in CD-1 female mice through fibroblast growth factor 21/mitochondrial dynamics mediation (PubMed, Wei Sheng Yan Jiu)
Lycopene ameliorated D-galactose-induced hepatic senescence and hepatic impairment, which may be associated with its activation of hepatic FGF21 signaling and enhancement of mitochondrial function.
Preclinical • Journal
|
TP53 (Tumor protein P53) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL10 (Interleukin 10) • FGF21 (Fibroblast Growth Factor 21) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • MFN1 (Mitofusin 1) • MFN2 (Mitofusin 2)
10ms
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CASP3 (Caspase 3) • IL1B (Interleukin 1, beta) • MFN1 (Mitofusin 1)
|
sirolimus
12ms
Disruption of Mitochondrial Dynamics and Stasis Leads to Liver Injury and Tumorigenesis. (PubMed, bioRxiv)
Mitochondrial dynamics and stability are essential for maintaining hepatic mitochondrial homeostasis and hepatocyte functions. Loss of hepatic DRP1 promotes liver tumorigenesis by increasing pyrimidine metabolism and activating the cGAS-STING-mediated innate immune response.
Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • STING (stimulator of interferon response cGAMP interactor 1) • DNM1L (Dynamin 1 Like) • MFN1 (Mitofusin 1) • MFN2 (Mitofusin 2)
1year
Endogenous interactomes of MFN1 and MFN2 provide novel insights into interorganelle communication and autophagy. (PubMed, Autophagy)
We characterized RAB5C (RAB5C, member RAS oncogene family) as an endosomal modulator of mitochondrial homeostasis, and SLC27A2 (solute carrier family 27 (fatty acid transporter), member 2) as a novel partner of MFN2 relevant in autophagy. We conclude that MFN proteins participate in nutrient-modulated pathways involved in organelle communication and autophagy.
Journal
|
MFN1 (Mitofusin 1) • MFN2 (Mitofusin 2) • RAB5C (RAB5C, Member RAS Oncogene Family)
over1year
Mitochondrial Dynamics in Non-Small Cell Lung Cancer. (PubMed, Cancers (Basel))
Increased mitochondrial fusion in the blood of lung cancer patients may suggest an increase in protective and repair mechanisms. This opens up questions about why these mechanisms fail in the context of existing advanced cancer disease and is a starting point for further research into why protective mechanisms fail in lung cancer patients.
Journal
|
MFN1 (Mitofusin 1)